Health Care/Hospital

Transcenta Holding Secures $100 Million Series B Plus Financing

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...

2020-01-08 21:00 409

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...

2020-01-07 22:00 290

Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries

FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...

2020-01-07 21:10 279

Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference

HONG KONG, SUZHOU, China and HANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- Transcenta Holding (Transcenta) today announced that Co-founder & CEO Dr. Xueming Qian will present at the 38th Annual J.P. Morgan Healthcare Conference onWednesday, January 15, 2020, at 14:30 PST in Golden Gate room at Wes...

2020-01-07 00:00 327

Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020

SAN MATEO, Calif. and ADELAIDE, Australia, Jan. 6, 2020 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out ofSan Mateo and South Australia, recently presented the results of groundbreaking research at the prestigious American Society for Reprod...

2020-01-06 23:47 300

Happiness Biotech Announces the Opening of its First Experience Store in Hainan, China, introducing the Company's 31st Experience Store

NANPING, China, Jan. 6, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the opening of its first experience store inHainan, China, which is the Company's 31st experience ...

2020-01-06 21:00 8154

Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification

BEIJING, Jan. 6, 2020 /PRNewswire/ -- Lianluo Smart Limited (the "Company") announced today that it has received a letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 2, 2020, providing notification that the Company no longer complies with the minimum of$2.5 mi...

2020-01-06 19:00 8322

CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs

SHANGHAI, Jan 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment ofYong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CAR...

2020-01-06 18:00 365

GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR

GUANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- The beginning of 2020 witnessed key projects promoting the cooperation betweenGuangdong and Macao. On January 3 , Guangzhou Pharmaceutical Group (Macau) International Development Co., Ltd. (hereunder referred to as "the company") was established inMac...

2020-01-06 14:39 351

Nunaps raises US$4.2M to develop patient-centered digital therapeutics platform for brain damage

SEOUL, South Korea, Jan. 5, 2020 /PRNewswire/ -- Nunaps, a South Korean digital therapeutics startup, has closed aKRW 5 billion (US$ 4.2 million) Series A round by Company K Partners, KTB Network, and K2 Investment Partners. The company plans to use the fresh capital to build digital therapeutics...

2020-01-06 12:54 388

111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020

SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will attend  the JP Morgan 2020 Healthcare Conference in San Francisco, CA, USA, January 14-15, 2020 and meet with ...

2020-01-04 08:00 5555

I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China

SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based inChina and the United States and focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases today announced the dosing o...

2020-01-04 00:07 1001

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

TAIZHOU, China, Jan. 3, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"),(NASDAQ: SXTC) announced today that on December 27, 2019 the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifyi...

2020-01-03 23:30 5815

Huami Corporation CEO Issues Open Letter to Staff

BEIJING, Jan. 3, 2020 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today announced that,Wang Huang, the Company's Chairman and CEO, issued the following open letter t...

2020-01-03 18:30 5643

AgriTalk Integrates Biotechnology, Iot, Big Data Analysis, and Ai to Develop a Non-Toxic Agricultural Disease and Fertilizer Regulation System

TAIPEI, Jan. 3, 2020 /PRNewswire/ -- AgriTalk and other notable homegrown startups led by Taiwan Tech Arena (TTA) are now showcasing their innovative solutions at CES 2020. Dr. W...

2020-01-03 13:14 418

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- STA Pharmaceutical Co., Ltd.,  (WuXi STA) – a subsidiary of WuXi AppTec – today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility inChangzhou, China. This signifi...

2020-01-03 08:10 528

Panzhihua, China: Creating a New Benchmark for the Recuperation and Health Preservation Industry

CHENGDU, China, Dec. 31, 2019 /PRNewswire/ -- In December 2019, the 10th Panzhihua Joy and Sunshine Festival kicked off under the joint sponsorship of the Panzhihua Municipal People's Government ofSichuan Province, China, and the Sichuan Provincial Department of Culture and Tourism. The Joy and S...

2019-12-31 17:04 770

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco

SHANGHAI and SUZHOU, China, Dec. 30, 2019 /PRNewswire/ -- Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences inSan Francisco, California at the beginning of January 2020. Gracell will present at the 38th ...

2019-12-30 23:09 592

Foresee-X Augment Reality Solution from SURGLASSES Is Registered with the FDA and Ready for Trauma Treatment

TAICHUNG, Taiwan, Dec. 30, 2019 /PRNewswire/ -- Foresee-X is a set of smart surgical glasses with functionality based on augmented and mixed reality technologies. This device was developed by SURGLASSES, also known as Taiwan Main Orthopaedic Biotechnology Co. Ltd., and has received IEC60601-1-2 a...

2019-12-30 14:27 518

Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC

* China NMPA cleared the IND application of BBT-401 submitted on September 25, 2019 * The Phase I clinical study in China will be initiated in May 2020 SEONGNAM, South Korea, Dec. 26, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KOSDAQ: 288330), a clinical stage biotech company headquart...

2019-12-27 06:30 566
12345678 ... 538